Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1010
-
Total 13F shares, excl. options
-
219M
-
Shares change
-
-844K
-
Total reported value, excl. options
-
$49.8B
-
Value change
-
-$353M
-
Put/Call ratio
-
0.99
-
Number of buys
-
455
-
Number of sells
-
-543
-
Price
-
$227.04
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2020
1,208 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2020.
Elevance Health, Inc. - Common Stock (ELV) has 1,010 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 219M shares
of 226M outstanding shares and own 97.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.4M shares), VANGUARD GROUP INC (20M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.6M shares), WELLINGTON MANAGEMENT GROUP LLP (11.3M shares), STATE STREET CORP (10.9M shares), Capital International Investors (8.12M shares), FMR LLC (7.5M shares), Invesco Ltd. (4.87M shares), BAILLIE GIFFORD & CO (4.1M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.72M shares).
This table shows the top 1010 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.